Sonali Narain is a Rheumatology/Immunology physician affiliated with Hofstra University. OpenAlex indexes 58 publications with 2,739 citations (h-index 26).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
865 Northern Blvd
Suite 302
Great Neck, NY 110215335
Telephone
516-708-2550Registry record last updated 13 Oct 2015.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202535 payments
- Janssen Scientific Affairs, LLCProgram year202534 payments
- PFIZER INC.Program year202512 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
31.1%Corticosteroid24%Prednisone100%Part D≥50 patientsProton pump inhibitor4.4%Pantoprazole Sodium100%Part D<11 patients+ 1 more class in this area
Cancer & immunology
25.7%Folate Analog Metabolic Inhibitor10.8%Methotrexate100%Part D≥22 patientsTNF inhibitor5%Enbrel Sureclick62%Humira(Cf) Pen38%Part D<11 patients+ 4 more classes in this area
Musculoskeletal
17.5%Xanthine oxidase inhibitor9.4%Allopurinol100%Part D≥15 patientsCentral alpha-2 Adrenergic Agonist3.4%Tizanidine Hcl100%Part D≥13 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus
Arthritis & Rheumatology
2025 - Time required to implement a computerized patient decision aid for lupus in outpatient visits
Implementation Science Communications
2025 - The differential role of SSa/SSb and Ro52 antibodies in defining clinical phenotypes in idiopathic inflammatory myopathies
Seminars in Arthritis and Rheumatism
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Iannuzzi, MD
Hofstra University
Jacqueline Barrientos, MD
Hofstra University
Sujana Chandrasekhar, MD
Hofstra University
Jamie Green, MD
Hofstra University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”